image
Tourmaline Bio, Inc. TRML
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 16.64
-1.13 %
$ 427 M
Market Cap
-5.15
P/E
Price Target Average
184.46%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
18.92%
Net Income Estimate
--8.05%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Tourmaline Bio, Inc.
image
Wall Street analysts predict an average 1-year price target for TRML of $47.3 , with forecasts ranging from a low of $42 to a high of $50 .
TRML Lowest Price Target Wall Street Target
42 USD 152.40%
TRML Average Price Target Wall Street Target
47.3 USD 184.46%
TRML Highest Price Target Wall Street Target
50 USD 200.48%
Price
Max Price Target
Min Price Target
Average Price Target
505045454040353530302525202015151010Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
REVENUE FORECAST

Revenue Forecast Chart TRML

image
$80.0m$80.0m$70.0m$70.0m$60.0m$60.0m$50.0m$50.0m$40.0m$40.0m$30.0m$30.0m$20.0m$20.0m$10.0m$10.0m$0.0$0.020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart TRML

image
$0.0$0.0($10.0m)($10.0m)($20.0m)($20.0m)($30.0m)($30.0m)($40.0m)($40.0m)($50.0m)($50.0m)($60.0m)($60.0m)($70.0m)($70.0m)($80.0m)($80.0m)20232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart TRML

image
$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)($120.0m)($120.0m)($140.0m)($140.0m)($160.0m)($160.0m)($180.0m)($180.0m)($200.0m)($200.0m)20232023202420242025202520262026202720272028202820292029